{"id":"W2899608945","doi":"10.1016/s2213-2600(18)30406-5","title":"Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; Francophone University Association; Vancouver General Hospital; University of British Columbia","funders":"Kyowa Hakko Kirin; Pearl Therapeutics; AstraZeneca","keywords":"Benralizumab; Medicine; Placebo; Tolerability; Clinical endpoint; Internal medicine; Adverse effect; Asthma; Clinical trial; Dosing; Mepolizumab; Eosinophil; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011117,0.0002870587,0.001006718,0.00009376426,0.0001714127,0.00001027467,0.0002586105,0.00011146,0.0001293185],"category_scores_gemma":[0.001273459,0.0001216924,0.0000679863,0.0003559007,0.001059169,0.00007428042,0.00008320495,0.0003431725,0.000009962696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005100457,"about_ca_system_score_gemma":0.0001867951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008932608,"about_ca_topic_score_gemma":0.000118948,"domain_scores_codex":[0.997286,0.0004334511,0.0007886885,0.0004461344,0.0006916703,0.0003540641],"domain_scores_gemma":[0.9973207,0.0007539344,0.0003997112,0.001053517,0.0002879479,0.0001841525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8627073,0.000906009,0.1040567,0.00004569347,0.0001678865,0.00007208098,0.0009957127,0.00000426909,0.0003540333,0.00004971564,0.004107794,0.02653284],"study_design_scores_gemma":[0.3490543,0.007729891,0.636535,0.000616744,0.0001653684,0.000002217116,0.0001005013,0.00001062844,0.00005684643,0.00001011209,0.005607802,0.000110603],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940904,0.001210542,0.00001558318,0.00175895,0.0002385484,0.001722981,0.0001427026,0.00003780665,0.0007824712],"genre_scores_gemma":[0.9943673,0.00005375513,0.00001799372,0.002381255,0.002997654,0.00001414101,0.00008865279,0.00003110703,0.00004812071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5324783,"threshold_uncertainty_score":0.4962474,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02642157700709075,"score_gpt":0.3072804654897434,"score_spread":0.2808588884826526,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}